This company has been marked as potentially delisted and may not be actively trading. LogicBio Therapeutics (LOGC) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipShort InterestSustainabilityTrendsBuy This Stock LOGC vs. BWMX, VGII, OG, WNW, OGBLY, MYTE, CARS, PLAY, SFIX, and ETDShould you be buying LogicBio Therapeutics stock or one of its competitors? The main competitors of LogicBio Therapeutics include Betterware de México, S.A.P.I. de C.V. (BWMX), Virgin Group Acquisition Corp. II (VGII), Onion Global (OG), Meiwu Technology (WNW), Onion Global (OGBLY), MYT Netherlands Parent B.V. (MYTE), Cars.com (CARS), Dave & Buster's Entertainment (PLAY), Stitch Fix (SFIX), and Ethan Allen Interiors (ETD). LogicBio Therapeutics vs. Its Competitors Betterware de México, S.A.P.I. de C.V. Virgin Group Acquisition Corp. II Onion Global Meiwu Technology Onion Global MYT Netherlands Parent B.V. Cars.com Dave & Buster's Entertainment Stitch Fix Ethan Allen Interiors Betterware de México, S.A.P.I. de C.V. (NASDAQ:BWMX) and LogicBio Therapeutics (NASDAQ:LOGC) are both small-cap catalog & mail - order houses industry companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings, media sentiment and risk. Does the media favor BWMX or LOGC? In the previous week, Betterware de México, S.A.P.I. de C.V. had 1 more articles in the media than LogicBio Therapeutics. MarketBeat recorded 1 mentions for Betterware de México, S.A.P.I. de C.V. and 0 mentions for LogicBio Therapeutics. Betterware de México, S.A.P.I. de C.V.'s average media sentiment score of 0.50 beat LogicBio Therapeutics' score of 0.00 indicating that Betterware de México, S.A.P.I. de C.V. is being referred to more favorably in the media. Company Overall Sentiment Betterware de México, S.A.P.I. de C.V. Positive LogicBio Therapeutics Neutral Do insiders & institutionals hold more shares of BWMX or LOGC? 12.7% of Betterware de México, S.A.P.I. de C.V. shares are owned by institutional investors. Comparatively, 46.1% of LogicBio Therapeutics shares are owned by institutional investors. 8.1% of LogicBio Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has stronger valuation & earnings, BWMX or LOGC? Betterware de México, S.A.P.I. de C.V. has higher revenue and earnings than LogicBio Therapeutics. LogicBio Therapeutics is trading at a lower price-to-earnings ratio than Betterware de México, S.A.P.I. de C.V., indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBetterware de México, S.A.P.I. de C.V.$14.17B0.04$59.29M$0.7916.96LogicBio Therapeutics$287M0.72-$317M-$5.79-1.36 Which has more volatility & risk, BWMX or LOGC? Betterware de México, S.A.P.I. de C.V. has a beta of 1.24, meaning that its share price is 24% more volatile than the S&P 500. Comparatively, LogicBio Therapeutics has a beta of 2.06, meaning that its share price is 106% more volatile than the S&P 500. Is BWMX or LOGC more profitable? Betterware de México, S.A.P.I. de C.V. has a net margin of 6.65% compared to LogicBio Therapeutics' net margin of -141.03%. Betterware de México, S.A.P.I. de C.V.'s return on equity of 83.11% beat LogicBio Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Betterware de México, S.A.P.I. de C.V.6.65% 83.11% 10.89% LogicBio Therapeutics -141.03%-81.98%-52.13% SummaryBetterware de México, S.A.P.I. de C.V. beats LogicBio Therapeutics on 9 of the 13 factors compared between the two stocks. Get LogicBio Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LOGC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LOGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LOGC vs. The Competition Export to ExcelMetricLogicBio TherapeuticsCatalog & mail IndustryRetail SectorNASDAQ ExchangeMarket Cap$207.09M$346.41M$27.54B$10.15BDividend YieldN/A7.49%173.91%4.60%P/E Ratio-1.363.1920.6225.92Price / Sales0.7216.448.4485.33Price / CashN/A58.4764.8459.91Price / Book0.883.904.816.29Net Income-$317M$4.74M$872.26M$270.77M LogicBio Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LOGCLogicBio Therapeutics1.0657 of 5 stars$7.88+1.3%N/A+45.4%$207.09M$287M-1.3662Gap DownBWMXBetterware de México, S.A.P.I. de C.V.N/A$13.63-0.8%N/A+8.5%$508.74M$14.17B9.741,270VGIIVirgin Group Acquisition Corp. IIN/A$1.52-0.7%N/A+15.0%$76.48MN/A0.00N/AOGOnion GlobalN/AN/AN/AN/A$25.02M$2.04B0.00796WNWMeiwu TechnologyN/A$2.18+10.7%N/A-87.1%$6.89M$158.49K0.0050Gap UpOGBLYOnion GlobalN/AN/AN/AN/A$11KN/A0.00860MYTEMYT Netherlands Parent B.V.1.8726 of 5 stars$9.62+1.5%$14.00+45.5%+139.4%$824.42M$881.44M-22.371,240News CoveragePositive NewsCARSCars.com3.6817 of 5 stars$13.21-2.2%$17.30+31.0%-18.7%$812.85M$719.15M21.341,800PLAYDave & Buster's Entertainment4.2838 of 5 stars$22.56-3.1%$33.50+48.5%-26.3%$780.30M$2.13B22.3423,420Positive NewsUpcoming EarningsSFIXStitch Fix2.1257 of 5 stars$5.75+0.8%$5.67-1.4%+61.6%$750.97M$1.34B-12.514,570News CoveragePositive NewsETDEthan Allen Interiors2.9153 of 5 stars$29.49-1.3%$30.00+1.7%+1.7%$750.06M$614.65M14.673,211News CoveragePositive NewsShort Interest ↓ Related Companies and Tools Related Companies Betterware de México, S.A.P.I. de C.V. Alternatives Virgin Group Acquisition Corp. II Alternatives Onion Global Alternatives Meiwu Technology Alternatives Onion Global Alternatives MYT Netherlands Parent B.V. Alternatives Cars.com Alternatives Dave & Buster's Entertainment Alternatives Stitch Fix Alternatives Ethan Allen Interiors Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LOGC) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored6-Figure Target for BTC by 2025Trump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredWall Street laughed at Trump’s “Smart Dollar.” Now they’re all in."THIS is the Biggest Economic Story of 2025" While most Americans are focused on tariffs and inflation, the...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LogicBio Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LogicBio Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LOGC Stock Alerts